Signaturefd, LLC Dexcom Inc Transaction History

Signaturefd, LLC

$5.21 Billion
Q4 2024

A detailed history of Signaturefd, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Signaturefd, LLC holds 6,561 shares of DXCM stock, worth $579,795. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,561

Previous 5,035 30.31%

Holding current value

$579,795

Previous $337,000 51.34%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$65.68 - $81.01 $100,227 - $123,621	1,526 Added 30.31%	6,561 $510,000
Q3 2024 Oct 21, 2024	SELL	$64.0 - $116.06 $294,784 - $534,572	-4,606 Reduced 47.78%	5,035 $337,000
Q2 2024 Jul 29, 2024	SELL	$110.31 - $140.45 $14,119 - $17,977	-128 Reduced 1.31%	9,641 $1.09 Million
Q1 2024 May 03, 2024	BUY	$114.22 - $140.1 $28,440 - $34,884	249 Added 2.62%	9,769 $1.35 Million
Q4 2023 Jan 31, 2024	BUY	$75.49 - $124.16 $55,862 - $91,878	740 Added 8.43%	9,520 $1.18 Million
Q3 2023 Nov 03, 2023	SELL	$86.06 - $137.93 $48,451 - $77,654	-563 Reduced 6.03%	8,780 $819,000
Q2 2023 Aug 01, 2023	BUY	$112.47 - $130.98 $7,310 - $8,513	65 Added 0.7%	9,343 $1.2 Million
Q1 2023 Apr 28, 2023	BUY	$104.0 - $122.92 $16,640 - $19,667	160 Added 1.75%	9,278 $1.08 Million
Q4 2022 Jan 27, 2023	BUY	$84.98 - $122.67 $82,090 - $118,499	966 Added 11.85%	9,118 $1.03 Million
Q3 2022 Nov 08, 2022	BUY	$76.35 - $94.18 $219,964 - $271,332	2,881 Added 54.66%	8,152 $657,000
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $249,659 - $487,972	3,672 Added 229.64%	5,271 $393,000
Q1 2022 May 02, 2022	SELL	$94.08 - $130.2 $3,857 - $5,338	-41 Reduced 2.5%	1,599 $818,000
Q4 2021 Jan 25, 2022	BUY	$129.87 - $162.82 $15,194 - $19,049	117 Added 7.68%	1,640 $881,000
Q3 2021 Oct 28, 2021	BUY	$106.71 - $143.18 $23,049 - $30,926	216 Added 16.53%	1,523 $833,000
Q2 2021 Jul 26, 2021	BUY	$80.99 - $107.93 $8,989 - $11,980	111 Added 9.28%	1,307 $558,000
Q1 2021 Apr 30, 2021	SELL	$84.79 - $104.74 $11,955 - $14,768	-141 Reduced 10.55%	1,196 $430,000
Q4 2020 Feb 11, 2021	SELL	$78.0 - $104.5 $18,408 - $24,662	-236 Reduced 15.0%	1,337 $494,000
Q3 2020 Nov 03, 2020	SELL	$95.51 - $112.95 $28,844 - $34,110	-302 Reduced 16.11%	1,573 $648,000
Q2 2020 Jul 30, 2020	BUY	$62.68 - $105.34 $21,185 - $35,604	338 Added 21.99%	1,875 $760,000
Q1 2020 Apr 23, 2020	BUY	$47.79 - $75.63 $21,123 - $33,428	442 Added 40.37%	1,537 $414,000
Q4 2019 Feb 05, 2020	BUY	$36.62 - $57.29 $1,025 - $1,604	28 Added 2.62%	1,095 $240,000
Q3 2019 Oct 16, 2019	BUY	$35.53 - $43.8 $1,883 - $2,321	53 Added 5.23%	1,067 $159,000
Q2 2019 Jul 31, 2019	SELL	$27.84 - $38.92 $306 - $428	-11 Reduced 1.07%	1,014 $152,000
Q1 2019 May 09, 2019	SELL	$28.07 - $38.18 $11,228 - $15,272	-400 Reduced 28.07%	1,025 $122,000
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $296 - $411	11 Added 0.78%	1,425 $171,000
Q1 2018 May 08, 2018	BUY	$13.06 - $18.54 $18,466 - $26,215	1,414 New	1,414 $105,000

Others Institutions Holding DXCM

# of Institutions

1,085

Shares Held

352M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account